Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Guy Neff
Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Related publications
Economic Impact of the Use of Rifaximin 550 Mg Twice Daily for the Treatment of Overt Hepatic Encephalopathy in Italy
Hepatic Medicine: Evidence and Research
Hepatology
PWE-153 Cost Effectiveness of Rifaximin-A in the Reduction of Recurrence of Overt Hepatic Encephalopathy
Gut
Gastroenterology
Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials
Journal of Clinical and Experimental Hepatology
Hepatology
Safety, Efficacy, and Patient Acceptability of Rifaximin for Hepatic Encephalopathy
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
The Economic Burden of Hyponatremia: Systematic Review and Meta-Analysis
American Journal of Medicine
Medicine
L-Ornithine L-Aspartate in Bouts of Overt Hepatic Encephalopathy
Hepatology
Medicine
Hepatology
The Economic Burden of Bronchiectasis – Known and Unknown: A Systematic Review
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
The Economic Burden of Physical Inactivity: A Systematic Review and Critical Appraisal
British Journal of Sports Medicine
Sports Medicine
Physical Therapy
Sports Science
Sports Therapy
Orthopedics
Medicine
Rehabilitation
Grading the Range of Hepatic Encephalopathy From Overt to Covert: Animals to the Rescue!
Hepatology
Medicine
Hepatology